← Eichor
Condition: Recurrent Non Muscle Invasive Bladder Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Recurrent Non Muscle Invasive Bladder Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Phase N/A · 6 location(s) · University of Washington · NCT07225127Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
Phase N/A · 1 location(s) · University of Zurich · NCT07494864Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer
Phase N/A · 1 location(s) · Jørgen Bjerggaard Jensen · NCT05337397Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Inte
Phase 3 · 1 location(s) · Fujian Medical University Union Hospital · NCT06441110A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Phase 1/Phase 2 · 20 location(s) · SURGE Therapeutics · NCT05710848Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer
Phase 2 · 1 location(s) · Paul Toren · NCT07420517Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients
NA · 1 location(s) · National Taiwan University Hospital · NCT05739968A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscl
Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT06733363PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bl
Phase 1 · 1 location(s) · University of California, Davis · NCT06173349Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
Phase 1/Phase 2 · 6 location(s) · Zhuhai Beihai Biotech Co., Ltd · NCT06732531Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06167356A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Phase 1/Phase 2 · 13 location(s) · Merck Sharp & Dohme LLC · NCT06637423Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Phase N/A · 3 location(s) · Early is Good Inc. · NCT05982561Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive B
Phase 3 · 6 location(s) · Verity Pharmaceuticals Inc. · NCT05037279A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Mi
Phase N/A · 1 location(s) · Peking University First Hospital · NCT06991868AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
Phase N/A · 44 location(s) · Association Francaise d'Urologie · NCT05002556Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthra
Phase 1 · 1 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT06766266Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer
Phase 4 · 8 location(s) · Jakob Kristian Jakobsen · NCT06781879Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recu
Phase 3 · 1 location(s) · Chengdu CoenBiotech Co., Ltd · NCT06241755Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Inva
Phase 3 · 58 location(s) · Alliance for Clinical Trials in Oncology · NCT07000084Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
Phase 2 · 1 location(s) · Michael A. O'Donnell · NCT07322263Prospective Sample Collection for Cancer of Bladder
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT03973671A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
Phase 1 · 6 location(s) · University of Wisconsin, Madison · NCT05521698Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy T
Phase 2 · 134 location(s) · National Cancer Institute (NCI) · NCT06770582
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.